2023 Annual Shareholders’ Meeting

1
Notice of 2023 Annual Shareholders’ Meeting
Notice is hereby given that the Annual Meeting of ArborGen Holdings Limited shareholders will be held at the Ellerslie Event Centre,
Ellerslie Racecourse, 100 Ascot Avenue, Remuera, Auckland in the Remuera Room, Level 1, The Ellerslie Stand
and online via www.meetnow.global/nz on Wednesday 20 September 2023 at 10:30am.
If the Company is prevented from being able to hold the Annual Meeting in person on the Meeting Date for any reason,
shareholders will only be able to join the meeting online at www.meetnow.global/nz. When participating online, shareholders will
require their shareholder number, found on the enclosed proxy form, for verification purposes.
To view and listen to the webcast please visit:
www.meetnow.global/nz or www.arborgenholdings.com
Please refer to the Virtual Meeting Guide at www.computershare.com/vm-guide-nz
Voting / Appointment of Proxy Form
Accompanying this document is a voting / appointment of proxy form to enable you to vote on the resolutions either by:
• attending the Annual Meeting;
• lodging a postal vote; or
• appointing a proxy to vote at the Annual Meeting.
If you do not plan to attend the Annual Meeting you are encouraged to complete and return the enclosed voting / appointment
of proxy form as soon as possible or lodge your postal vote / proxy online.
Important Dates
5:30pm, Saturday 16 September 2023 Record Date for voting entitlements for the Annual Shareholders’ Meeting
10:30am, Monday 18 September 2023 Latest time for online lodgement / receipt of postal votes and proxy forms
10:30am, Wednesday 20 September 2023 Annual Meeting of Shareholders
All dates / times are given in New Zealand time.
Business of the Meeting
i. Chairman’s address
ii. Chief Executive Officer’s review
iii. Shareholder questions
iv. Resolutions
Shareholders will be asked to consider and, if thought appropriate, pass ordinary resolutions on the following matters:
Re-election of Director
1. That Paul Smart be re-elected as a Director of the Company. In accordance with the Director rotation requirements under NZX
Listing Rule 2.7, Mr Smart retires as a Director at the meeting and, being eligible, offers himself for re-election. A biography of
Mr Smart is contained in Explanatory Note 1.
Chief Executive Officer’s Remuneration – Issuance of Shares
2. That the Company be authorised to issue 10,471,477 restricted ordinary shares to its Chief Executive Officer, Mr Justin Birch, as part of
Mr Birch’s remuneration arrangements in accordance with NZX Listing Rule 4.2.1 and on the terms described in Explanatory Note 2.
Auditor’s Remuneration
3. To authorise the Directors to fix Deloitte’s fees and expenses as the Company’s auditor for the year ending 31 March 2024.
See Explanatory Note 3.

2
PROCEDURAL NOTES
a. Each of Resolutions 1, 2 and 3 is an ordinary resolution and must be passed by a simple majority of the votes of those shareholders
entitled to vote and voting on the resolutions.
b. David Knott (including Dorset Management Corporation), who holds 26.7% of the shares on issue, has confirmed he intends to vote
in favour of all resolutions.
c. The persons who will be entitled to vote on the resolutions at the Annual Meeting are those persons who are recorded on the
register as shareholders at 5:30pm on 16 September 2023 (Record Date).
d. The accompanying voting / appointment of proxy form should be used to vote on the resolutions. You can participate by postal vote,
by proxy, or by casting your vote in person at the Annual Meeting.
e. A shareholder that is entitled to attend and vote at the Annual Meeting is entitled to appoint a proxy (or a representative in the case
of a corporate shareholder) to attend and vote on their behalf. The proxy does not need to be a shareholder of the Company.
f. You may appoint the Chair of the meeting or any Director as your proxy if you would like. The Chair of the meeting and the Directors
confirm that they will vote in favour of resolutions marked “Proxy Discretion”, even if they have an interest in the outcome of the
resolution.
g. If, in appointing your proxy, you do not name a person to be your proxy or your named proxy does not attend the meeting, the
Chair of the meeting will be appointed as your proxy and may only vote in accordance with your express direction, including “Proxy
Discretion” (subject to any voting restrictions).
h. A shareholder may cast a postal vote instead of attending the meeting in person or appointing a proxy to attend.
Sharon Ludher-Chandra, the Company Secretary, has been authorised by the Board to receive and count postal votes.
i. A shareholder can elect to lodge their proxy appointment or postal vote online as per the instructions in the Voting / Appointment
of Proxy form.
j. In accordance with NZX Listing Rule 6.3.1, Mr Justin Birch (as the person to whom it is proposed the shares referred to in Resolution
2 would be issued) and any Associated Persons (as defined in the NZX Listing Rules) of Mr Birch, will not vote any shares that he or
she holds or controls in favour of Resolution 2.
By Order of the Board
Auckland Sharon Ludher-Chandra
New Zealand Company Secretary
18 August 2023 ArborGen Holdings Limited

3
EXPLANATORY NOTES
1. Resolution 1 – Re-election of Paul Smart
Ordinary resolution: “That Paul Smart be re-elected as a Director of the Company.”
Paul Smart – Independent Director
BBS, Finance Massey University; Chartered Accountant (CA); Chartered Member Institute of Directors (CMinstD)
The Board considers that, if re-elected, Paul will qualify as an independent director for the purposes of the NZX Listing Rules
because he is not an executive of ArborGen and does not have any Disqualifying Relationships as defined in the NZX Listing Rules.
Mr Smart, who is based in New Zealand, brings broad industry knowledge to the Board. He has more than 30 years’ experience
as a senior financial executive and professional director in local and international markets, including listings on the NZX, ASX and
NASDAQ.
As an executive, Mr Smart’s key experiences were as CFO of NZ’s largest energy company, Meridian Energy and prior to that,
founding CFO of Sky Television which during his tenure went on to become a top 10 listed company on the NZX. As a professional
director Mr Smart has variously acted as a director, audit and finance chair and board chair for a broad range of companies including
listed, venture capital, high-net-worth family, and large private companies.
Relevant experience to ArborGen has been as a founding group member, Chair and director of Tamata Hauha a New Zealand
company planting trees in long term partnerships with landowners for the carbon market or for production forestry. In an aligned
industry Mr Smart is currently a director of Genesis IntelliGen Technologies NZ business, part of a world leading Group which
pioneers genetic animal improvement through its broad multinational operations, including the United States and Europe.
The Board unanimously recommend shareholders vote in favour of the re-election of Mr Smart.
2. Resolution 2 – Chief Executive Officer’s Remuneration
Ordinary resolution: “That the Company be authorised to issue 10,471,477 ordinary shares to its Chief Executive Officer, Mr Justin
Birch, as part of Mr Birch’s remuneration arrangements in accordance with NZX Listing Rule 4.2.1 and on the terms described in
Explanatory Note 2.”
Background
On 26 April 2023, the Company announced the appointment of Mr Birch as President and Chief Executive Officer of ArborGen Inc
and Chief Executive Officer of the Company following a comprehensive and extensive search process. Mr Birch commenced his
employment with the ArborGen Group on 1 June 2023 (the Starting Date).
The remuneration arrangements that were agreed with Mr Birch under his employment agreement with ArborGen Inc dated 23 May
2023 (as amended from time to time, the Employment Agreement) are summarised below. These arrangements are intended to
strongly align his interests with those of ArborGen shareholders.
● A fixed remuneration component comprising cash salary of US$425,000 (Base Salary).
● Annual short-term incentive of up to 100% of Base Salary:
○ Guaranteed for and paid after ArborGen’s fiscal year ended 31 March 2024 comprising:
» US$212,500 paid in cash; and
» US$212,500 in ordinary shares in the Company (ARB Shares).
○ For fiscal year ended 31 March 2025 and each fiscal year thereafter:
» a cash bonus of up to 50% of then-current Base Salary; and
» a bonus paid in ARB Shares of up to 50% of then-current Base Salary, in each case subject to meeting performance criteria
determined by the Company’s remuneration committee (the Remuneration Committee).
● An equity grant of restricted ARB Shares (Restricted Shares) under the Company’s 2019 Omnibus Incentive Scheme (the Plan)
equal to 4% of the ARB Shares, or a total of 20,251,477 Restricted Shares, subject to shareholder approval, as required (the Equity
Grant). The Plan permits the Board of the Company or the Remuneration Committee to grant various equity-based awards to
officers, employees and directors of the ArborGen Group, with the aim of aligning the interests of the Groups’ officers, employees
and directors with those of the Company’s shareholders over the longer term. The following vesting restrictions apply to the Equity
Grant:
○ 50% Time-Based Shares: 50% of the Restricted Shares shall vest as follows:
» one third shall vest on the first anniversary of the Starting Date (i.e., 1 June 2024); and
» two thirds shall vest on the second anniversary of the Starting Date (i.e., 1 June 2025),
in each case subject to completion of continuous service with the Company or an affiliate until the applicable vesting date;
and

4
○ 50% Performance-Based Shares: 50% of the Restricted Shares shall vest as follows:
» one half of such Performance-Based Shares shall vest on 1 June 2024; and
» the other half of such Performance-Based Shares shall vest on 1 June 2025,
in each case subject to satisfaction of applicable performance criteria determined by the Remuneration Committee and to
completion of continuous service with the Company or an affiliate until the applicable vesting date.
The performance-based criteria will be the Company, on a consolidated basis, achieving the EBITDA for the relevant financial
year set out in the budget presented, or to be presented, to the Board at the start of that financial year, adjusted for certain
agreed unbudgeted incremental expenses.
● A sign-on bonus of US$100,000.
● Relocation and legal reimbursement costs.
Issuance of Initial Tranche of Restricted Shares
On 27 July 2023, as part of the Equity Grant and pursuant to a Restricted Shares Agreement between the Company and Mr Birch
(the Restricted Shares Agreement), the Board issued 9,780,000 Restricted Shares (the First Tranche Restricted Shares and that
issuance the First Tranche Issuance) to the Trustee (as defined below) under NZX Listing Rule 4.6.1.
NZX Listing Rule 4.6.1 permits the Company to issue shares of a class which is already on issue to an employee (or to a trustee to
hold for the benefit of that employee) without approval by ordinary resolution of shareholders if the number to be issued, together
with any other shares of that class issued under NZX Listing Rule 4.6.1 over the previous 12 months, will not exceed 3% of the total
number of shares of that class on issue at the start of that 12-month period.
Half of the First Tranche Restricted Shares are subject to the time-based vesting criteria, with the other half being subject to the
performance-based vesting criteria. A summary of the First Tranche vesting is provided in the Equity Grant section below.
Balance of the Restricted Shares
Issuing the balance of the Restricted Shares under the Equity Grant, being 10,471,477 ARB Shares, to Mr Birch (the Second Tranche
Restricted Shares and that issuance the Second Tranche Issuance) would exceed the 3% threshold under NZX Listing Rule 4.6.1.
Accordingly, as required under the terms of Mr Birch’s Employment Agreement, the Company is seeking approval of shareholders
by ordinary resolution in accordance with NZX Listing Rule 4.2.1 to issue the Second Tranche Restricted Shares to Mr Birch. The
Second Tranche Issuance would occur as soon as practicable after the relevant shareholder approval is obtained.
Half of the Second Tranche Restricted Shares will be subject to the time-based vesting criteria, with the other half being subject to
the performance-based vesting criteria.
Equity Grant
The table below summarises the Equity Grant comprising (i) the First Tranche Restricted Shares issued on 27 July 2023, and (ii) the
Second Tranche Restricted Shares, being the shares for which shareholder approval is being sought under Resolution 2.
Total Equity GrantFirst Tranche
Restricted Shares
Second Tranche
Restricted Shares*
To t a l
Time-Based Shares4,890,0005,235,73910,125,739
Perfomance-Based Shares4,890,0005,235,73910,125,739
To t a l9,780,00010,471,47720,251,477
* Subject To Shareholder Approval Of Resolution 2
The table below summarises the vesting schedule of the First Tranche Restricted Shares (in each case subject to satisfaction of the
relevant vesting criteria).
First Tranche Restricted SharesVesting on
1 June 2024
Vesting on
1 June 2025
Total First Tranche
Restricted Shares
Time-Based Shares1,630,0003,260,0004,890,000
Perfomance-Based Shares2,445,0002,445,0004,890,000
Total Shares Vested4,075,0005,705,0009,780,000
EXPLANATORY NOTES continued

5
The table below summarises the vesting schedule of the Second Tranche Restricted Shares (in each case subject to satisfaction of
the relevant vesting criteria).
Second Tranche Restricted Shares*Vesting on
1 June 2024
Vesting on
1 June 2025
Total Second Tranche
Restricted Shares
Time-Based Shares1,745,2463,490,4925,235,739
Perfomance-Based Shares2,617,8692,617,8695,235,739
Total Shares Vested4,363,1156,108,36210,471,477
* Subject To Shareholder Approval Of Resolution 2
The First Tranche Issuance had the effect of diluting existing ARB shareholders by 1.90%. The Second Tranche Issuance would have
the effect of diluting ARB shareholders by a further 1.99%. These Restricted Shares still remain subject to the applicable vesting
criteria. Set out below is an example illustrating the total dilutive effect of the Equity Grant on a shareholder (Shareholder A) who
held 1.00% of the total ARB shares on issue prior to the First Tranche Issuance.
Number of shares held by Shareholder A 5,062,869
% of ARB equity before First and Second Tranche Issuances 1.000%
% of ARB equity after First and Second Tranche Issuances 0.962%
Effective dilution -3.85%
If Resolution 2 is passed and the Second Tranche Restricted Shares are issued to Mr Birch, the ultimate shareholding of Mr Birch
would comprise 3.85% of the total ARB shares on issue immediately after the Second Tranche Issuance.
Restricted Share Arrangements
Pending satisfaction of the relevant vesting criteria, Mr Birch must not sell, assign, transfer, pledge, mortgage or otherwise
encumber any of the applicable Restricted Shares (or receive any dividends paid in respect of the Restricted Shares unless and until
the applicable Vesting Criteria for that Restricted Share has been satisfied).
If the relevant vesting criteria is not satisfied, the applicable Restricted Shares (and any dividends payable in respect of those
Restricted Shares) will be forfeited for nil consideration.
In order to provide the Company and its shareholders with a higher level of comfort in relation to the enforcement of the relevant
transfer restrictions and the forfeiture arrangements which apply to the Restricted Shares, the First Tranche Restricted Shares were,
and the Second Tranche Restricted Shares will be, issued to a trust which is connected with the Company (the Tr u s t, and the trustee
of the Trust the Trustee).
Mr Birch is responsible for any required withholding taxes in respect of the Restricted Shares. Consistent with the terms of the Plan,
if Mr Birch fails to make such tax payments as required, the Company shall, to the extent permitted by law, have the right to deduct
all taxes required by law to be withheld with respect to the Restricted Shares. Notwithstanding the foregoing, and in accordance
with the terms of the Plan, the Company will, to the extent possible, as reasonably determined by the Remuneration Committee
after consultation with Mr Birch, either (i) withhold, cancel and surrender (or hold as treasury stock) Restricted Shares to which Mr
Birch is otherwise entitled, or (ii) sell such Restricted Shares from the Trust, in either case to satisfy Mr Birch’s tax liabilities with
respect to the Restricted Shares.
The Board in its sole discretion may elect, but shall not be obligated, to provide for full vesting of the Performance-Based Shares
for both fiscal years ending 31 March 2024 and FY 2025 if (i) vesting of the Performance-Based Shares did not occur and (ii) either
(1) the Company’s EBITDA for fiscal year ending 31 March 2026 was in the Board’s view materially greater than the prior years, or
(2) a Change in Control (as defined in the Plan) occurs in 2026 and the Board determines that it is appropriate in the circumstances,
which could include but would not be limited to a sale of the Company at an attractive price.
Consequences if Resolution 2 is not Passed
If Resolution 2 is not passed by the requisite majority, the Company will not issue the Second Tranche Restricted Shares to Mr Birch.
However, under the terms of Mr Birch’s Employment Agreement, the Company would then be required to negotiate in good faith
with Mr Birch to enter into a management incentive programme whereby Mr Birch would receive an appropriate bonus in cash
upon the earlier of (i) the achievement of a strategic transaction by (whether directly or indirectly) the Company or ArborGen Inc,
as applicable, and (ii) the seventh anniversary of the Starting Date.
Rationale and Recommendation
The Board believes that the Equity Grant was critical to attracting Mr Birch to the Company, and has been carefully structured with
the intention of motivating and retaining him. The strong emphasis on equity-based remuneration for Mr Birch is designed to align
his interests with those of the Company and its shareholders.
The Directors unanimously recommend that shareholders vote in favour of this resolution.
EXPLANATORY NOTES continued

6
3. Resolution 3 – Auditor’s Remuneration
Ordinary resolution: “To authorise the Directors to fix Deloitte’s fees and expenses as the Company’s auditor for the year ending
31 March 2024.”
Deloitte is automatically re-appointed at the Annual Meeting as auditor of the Company by virtue of section 207(T) of the
New Zealand Companies Act 1993 (the Companies Act). The proposed ordinary resolution is required to authorise the Directors of
the Company to fix Deloitte’s fees and expenses for the following year for the purposes of section 207(S) of the Companies Act.
The Directors unanimously recommend that shareholders vote in favour of this resolution.
EXPLANATORY NOTES continued

---

2023 Annual Shareholders’ Meeting
Voting
RESOLUTIONS
Signed: Date:
Signed: (Joint holders should all sign)
Shareholders should tick only one box for each resolution otherwise their vote will be treated as an abstention in respect of that resolution.
Appointment of Proxy
I/We (full name)
of the address above and being a shareholder(s) of ArborGen Holdings Limited
fo hereby appoint
(full name of proxy)
(full name of proxy)
(full address)
(full address)
fo or failing him/her

Signed: Date:
Signed: (Joint holders should all sign)
(please tick the appropriate box)
ForAgainstAbstainProxy Discretion

as my/our proxy to vote for me/us on my/our behalf on the resolutions set out in the Notice of Meeting and on any other matters appropriately put to
the 2023 Annual Shareholders’ Meeting of ArborGen Holdings Limited to be held on Wednesday 20 September 2023 at the Ellerslie Event Centre, Ellerslie
Racecourse, 100 Ascot Avenue, Remuera, Auckland in the Remuera Room at 10:30am, and at any adjournment or postponement of that meeting so as to give
effect to my/our intention as set out above.
If you tick the For, Against or Abstain boxes of the “Voting” section of this form you are directing your proxy to vote in the manner indicated.
If you tick the Proxy Discretion box in the “Voting” section of this form, your proxy may vote as he or she thinks fit. A person appointed as a proxy will not be
able to vote on amendments or resolutions from the floor of meeting unless the Proxy Discretion box in the “Voting” section of this form has been ticked. If
you do not tick one of the For, Against, Abstain or Proxy Discretion boxes for each resolution then your vote will be treated as an abstention in respect of
that resolution.
1. To re-elect Paul Smart as a Director of the Company.
2. To issue 10,471,477 restricted ordinary shares to its Chief Executive Officer,
Mr Justin Birch.
3. To authorise the Directors to fix Deloitte’s fees and expenses as the Company’s
auditor for the year ending 31 March 2024.
To be held at the Ellerslie Event Centre, Ellerslie Racecourse, 100 Ascot Avenue, Remuera, Auckland
in the Remuera Room, Level 1, The Ellerslie Stand and online on Wednesday 20 September 2023 at 10:30am.
To view and listen to the webcast please visit www.meetnow.global/nz or www.arborgenholdings.com.
If you wish to attend the meeting please bring this admission card and form intact.
If you are not attending the meeting and would like to either cast a postal vote or nominate a person to act as your
proxy, please complete the appropriate sections below and post or scan and email this form so that it is received by
Computershare Investor Services no later than 10:30am, 18 September 2023 (New Zealand time). You can also cast a
postal vote or appoint a proxy online (see instructions below and overleaf).
Voting Instructions
You may cast your vote in one of four ways:
• online – see instructions on the right
• by personally attending the meeting;
• by appointing a proxy to attend the meeting; or
• by making a postal vote.
ONLINE LODGEMENT
Lodge your postal vote or appoint your proxy online, 24 hours a day, 7 days a week.
Using your smartphone, scan the QR code above to vote now.
Using a computer, visit www.investorvote.co.nz
PLEASE NOTE: You will need the control number, your CSN/Security Holder Number and
postcode or country of residence (if outside New Zealand) to securely access InvestorVote and
then follow the prompts to lodge your postal vote or appoint your proxy online.
For your online proxy or postal vote to be effective, it must be received by 10:30am,
Monday 18 September 2023 (New Zealand time).
Voting Restriction
In accordance with NZX Listing Rule 6.3.1, Mr Justin Birch (as the person to whom it is proposed the shares referred to in Resolution 2 would be issued)
and any Associated Persons (as defined in the NZX Listing Rules) of Mr Birch, will not vote any shares that he or she holds or controls in favour of
Resolution 2.
Smartphone
QR code to
vote now

Fold
Tape here
Fold
Tape here
Tape here
ArborGen Holdings Limited
c/- Share Registrar
Computershare Investor Services Limited
Private Bag 92119
Auckland 1142
New Zealand
FreePost Authority No. 156689
NO POSTAGE REQUIRED
IF POSTED IN NEW ZEALAND
If you wish to attend the 2023 Annual Meeting, please bring this form with you to the meeting.
If you wish to appoint a proxy, please complete the “Appointment of Proxy” and “Voting” sections of this form and post or scan and email the whole
form to Computershare Investor Services or lodge online*. Please note:
• You should direct your proxy (who need not be a shareholder of the Company) as to how to vote on the resolutions by indicating your
voting preferences in the boxes provided in the voting section of this form.
• If you wish, you may appoint as your proxy “The Chair of the Meeting” or any Director. If you appoint the “Chair of the Meeting”, your proxy
for each resolution will be exercised by the Chair presiding at the time the resolution is voted on. The “Chair of the Meeting” and the
Directors have confirmed that they will vote any discretionary proxies held by them in favour of resolutions 1, 2 and 3.
• If, in appointing your proxy, you do not name a person to be your proxy or your named proxy does not attend the meeting, the Chair will be
appointed as your proxy and will vote in accordance with your express direction, including “Proxy Discretion” (subject to any voting prohibitions).
• You may still participate in the meeting even if you have appointed a proxy (but will not be able to vote if a proxy has been appointed).
If you wish to cast a postal vote, please indicate your vote preferences in the “Voting” section of this form and post or scan and email the completed
form to Computershare Investor Services or lodge online*.
* This form and the power of attorney or other authority, if any, under which it is signed, or a copy of that power of attorney (unless otherwise deposited with
the Company) and a signed certificate of non-revocation of the power of attorney must be deposited at Computershare Investor Services by email to
corporateactions@computershare.co.nz, no later than 10:30am on Monday 18 September 2023 (New Zealand time).
Signing Instructions:
This form must be signed by the shareholder/s or his/her attorney duly authorised in writing, or, if the shareholder is a company, by an officer or
attorney duly authorised. Joint holders and Trustees should all sign this form.
If your proxy will be attending the meeting remotely, please ensure that you provide their contact details (phone and email address). If this
information is not provided, we cannot guarantee remote admission to the virtual meeting for your proxy.
Proxy contact details (phone): and (email):
Voting Instructions continued

---

Attending the meeting online
Our online meeting provides you the opportunity to
participate online using your smartphone, tablet or computer.
If you choose to attend online you will be able to view a live
webcast of the meeting, ask questions and submit your
votes in real time.
You
will need the latest version of Chrome, Safari or
Edge. Please ensure your browser is compatible.
HOW TO PARTICIPATE IN VIRTUAL/HYBRID MEETINGS
Visit https://meetnow.global/nz
When successfully authenticated, the home screen
will be displayed. You can watch the webcast, vote,
ask questions, and view meeting materials in the
documents folder. The image highlighted blue
indicates the page you have active.
The webcast will appear and begin automatically
once the meeting has started.
Voting
Resolutions will be put forward once voting is
declared open by the Chair. Once the voting has
opened, the resolution and voting options will appear.
To vote, simply select your voting direction from the
options shown on screen. You can vote for all
resolutions at once or by each resolution.
Your vote has been cast when the green tick appears.
To change your vote, select ‘Change Your Vote’.
Q&A
Any eligible shareholder/proxy attending the meeting
r
emotely is eligible to ask a question.
S
elect the Q&A tab and type your question into the
box at the bottom of the screen and press 'Send'.
Navigation
Access
Access the online meeting at
https://meetnow.global/nz, and select the required
meeting. Click 'JOIN MEETING NOW'.
If you are a shareholder:
Select 'Shareholder' on the login screen and enter
your CSN/Holder Number and Post Code. If you are
outside New Zealand, simply select your country
from the drop down box instead of the post code.
Accept the Terms and Conditions and click Continue.
If you are a guest:
Select Guest on the login screen. As a guest, you will
be prompted to complete all the relevant fields
including title, first name, last name and email
address.
Please note, guests will not be able to ask questions
or vote at the meeting.
If you are a proxy holder:
You will receive an email invitation the day before the
meeting to access the online meeting. Click on the
link in the invitation to access the meeting.
Contact
If you have any issues accessing the website please
c
all +64 9 488 8700.